Congress Materials

Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Albanez J, Pithavala YK, Chen J March 18, 2022 ASCPT 2022 Lung Cancer

A Post Hoc Analysis of Potential Ethnic Differences in Lorlatinib Pharmacokinetics in Patients With Advanced ALK-Positive Non-Small Cell lung Cancer (NSCLC)

View Presentation
Poster
Davydov S, Tan W March 18, 2022 ASCPT 2022 Lung Cancer

Application of Long Short-Term Memory Recurrent Neural Network in Population Pharmacokinetic Modeling

View Presentation
Poster
Williams JH, Reddy M, Zhang Y, Del Frari L, Matschke K, Litwiler K March 18, 2022 ASCPT 2022 Skin Cancer

Effect of Encorafenib in Combination With Binimetinib on Substrates for OATP1B1/3, BCRP, and CYP2B6 in Patients With BRAF V600-Mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors

View Presentation
Poster
Liu J, Lin S, Huynh A, Tan W March 18, 2022 ASCPT 2022 Lung Cancer

Effects of H2-Receptor Antagonists on Dacomitinib Exposure

View Presentation
Poster
Dinh M, Pithavala YK, Chen J March 18, 2022 ASCPT 2022 Lung Cancer

Evaluation of Lactate Dehydrogenase (LDH) as a Marker for Lorlatinib Efficacy in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

View Presentation
Poster
Darragjati M, Li J, Pithavala YK, Chen J March 18, 2022 ASCPT 2022 Lung Cancer

Exposure-Response Relationship Between Lorlatinib Plasma Exposure and Increase in Blood Pressure in Patients With Advanced Anaplastic Lymphoma Kinase–Positive Non-Small Cell Lung Cancer

View Presentation
Poster
Piscitelli J, Pithavala YK, Chen J March 18, 2022 ASCPT 2022 Lung Cancer

Lorlatinib Population Pharmacokinetic Model With Mechanistic Nonlinear Clearance

View Presentation
Poster
Alidoost M, Nickens DJ, Alhadab A March 18, 2022 ASCPT 2022 Other/Multi-Tumor

Machine Learning (ML) Methods for Progression-Free Survival (PFS) and Overall Survival (OS) Prediction: Reanalysis of JAVELIN Head and Neck 100 Data

View Presentation
Poster
Zhou L, Liao K, Yin D, Chen X, Masters JC March 18, 2022 ASCPT 2022 Other/Multi-Tumor

Population Pharmacokinetics of Sasanlimab in Patients With Solid Tumors: Modeling-Based Analysis of Data From the First-in-Patient Trial

View Presentation